Clearwater Paper Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Clearwater Paper Corporation on November 1, 2024. The report details the completion of a major strategic transaction involving the divestiture of the Company's consumer product division.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of assets and membership interests.
- Assets Sold:
- 100% of Clearwater Paper Tissue, LLC (facilities in Las Vegas, NV; Elwood, IL; Shelby, NC).
- Assets and liabilities of the consumer product division facility in Lewiston, ID.
- Buyer: Sofidel America Corp. and its wholly owned subsidiary.
- Consideration: Approximately $1.06 billion in cash.
- Adjustments: The final amount is subject to adjustments for working capital, indebtedness, cash, and transaction expenses.
- Pro Forma Data: Unaudited pro forma financial statements are included as Exhibit 99.1 but specific numerical values for revenue, profit, or debt are not detailed in the text of this filing.
Material Changes
The primary material change is the exit from the consumer tissue business segment. This transaction removes the specified facilities and associated liabilities from Clearwater Paper's balance sheet, fundamentally altering the Company's asset base and operational footprint as of the closing date.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on future strategy, or specific risk factors beyond the standard incorporation by reference of the purchase agreements. The transaction is subject to standard closing adjustments which could impact the final net proceeds.
Investor Verification Checklist
- Verify the final purchase price after working capital and debt adjustments.
- Review the Unaudited Pro Forma Condensed Balance Sheet (Exhibit 99.1) to assess the impact on leverage and liquidity.
- Examine the Membership Interest Purchase Agreement (Exhibit 2.1) and Asset Purchase Agreement (Exhibit 2.2) for retained liabilities or earn-out provisions.
- Confirm the allocation of the $1.06 billion proceeds (e.g., debt repayment vs. share buybacks vs. retained cash).